The interrelationship of viral ribonucleic acid (RNA) and protein synthesis in cells infected by Sindbis virus was investigated. When cultures were treated with puromycin early in the course of infection, the synthesis of interjacent RNA (26S) was preferentially inhibited. A similar result was obtained by shifting cells infected by one temperature-sensitive mutant defective in RNA synthesis from the permissive (29 C) to the nonpermissive (41.5 C) temperature. Under both conditions, the viral RNA produced appeared to be fully active biologically. Once underway, the synthesis of viral RNA in wild-type Sindbis infections did not require concomitant protein synthesis.
The synthesis of infectious ribonucleic acid (RNA) in cells infected by a group A arbovirus, Western equine encephalomyelitis virus, has been shown to require concomitant protein synthesis. When cells actively synthesizing viral RNA were treated with puromycin, further production of infectious RNA promptly ceased (15) . Similar results were obtained when the synthesis of functional protein was blocked with fluorophenylalanine (17) . The most likely explanation for these findings is the lability of some enzyme involved in viral RNA synthesis.
We were surprised, therefore, that a somewhat comparable experiment performed with most temperature-sensitive (TS) mutants of Sindbis virus, a related group A arbovirus, did not yield a similar result. In these studies, mutants defective in viral RNA synthesis (RNA-) were allowed to infect cultures at a permissive temperature for several hours and then the cultures were shifted to a nonpermissive temperature. This temperature shift should effectively prevent further expression of a gene involved in viral RNA synthesis, thus paralleling the more general effects of an inhibitor of protein synthesis. Most RNA-mutants tested showed unimpaired synthesis of viral RNA and normal production of virus at the nonpermissive temperature (2, 12; unpublished results) . Thus, at least one enzyme involved in the synthesis of viral RNA did not appear to be labile.
Therefore, we reinvestigated the interrelationship of viral RNA and protein synthesis in cells infected by wild-type Sindbis virus. This problem is now known to be complicated by the fact that cells infected with group A arboviruses contain at least four types of virus-specific RNA: (i) 42S, ribonuclease-sensitive RNAlike that found in the virion; (ii) 20S, ribonuclease-resistant, replicative form RNA; (iii) partially ribonuclease-resistant, replicative intermediate RNA; (iv) 26S, ribonuclease-sensitive RNA that has been given the convenient name "interjacent RNA" (14) .
The first three species of RNA find their parallels in infections by a variety of animal and bacterial RNA viruses, and their functions have been reasonably well established. In contrast, the function (if, indeed, there is one) of the interjacent RNA is unknown. Recent evidence indicates that certain conditions allow an interconversion of interjacent and virion RNA (16) . Hence, these species may represent different conformational states of the same molecule (14, 16) . Elucidation of the conditions that determine the distribution of virus-specific RNA between these two species may be useful in assessing the function of the interjacent RNA. While examining the interrelationship of viral RNA and protein synthesis, we encountered two treatments that result in a preferential inhibition of the synthesis of interjacent RNA.
MATERIALS AND METHODS
Tissue culture and viruses. Primary chick embryo fibroblast cultures were prepared as described by Pfefferkorn and Clifford (10 (Fig. IA) . Probably, the amount of viral RNA polymerase synthesized during the first hour of infection was simply insufficient for detectable incorporation of 3H-uridine. However, once underway, viral RNA synthesis was quite insensitive to puromycin (Fig. 1B-D) .
We have already presented evidence that the virus-specific RNA synthesized in the presence of puromycin added 5 hr after infection is normal with respect to its sedimentation pattern (13) . Moreover, preliminary experiments have shown no significant effect of puromycin on the infectious RNA content of the cells. Thus, the syn- , one-half of them were treated with 50 ,ug of puromycin per ml (0), whereas the others served as controls (0). Drug-treated and control cultures were labeled continuously after puromycini addition with 3H-uridine (3.3 mc/mmole; I ,uc/ml) anid were removed at specified intervals for determiniation of labeled RNA.
thesis of viral RNA does not appear to require concomitant protein synthesis. Sindbis virus appears to differ from Western equine encephalomyelitis virus in this respect.
Inhibition of protein synthesis during the exponential phase of viral RNA synthesis. Experiments in which protein synthesis was inhibited by puromycin 1.5 hr after infection yielded a paradoxical result that is best described by reference to Fig. 2 . Puromycin had little effect on infectious RNA synthesis for the following 2.5 hr, although production of virus-specific RNA, as measured by incorporation of "4C-uridine in the presence of actinomycin D, was markedly reduced. Note that these data do not indicate the production of noninfectious RNA but rather the production of more infectious RNA per virusspecific RNA.
A possible explanation of this paradox lay in the observation that the interjacent RNA found in cells infected by other group A arboviruses has little or no infectivity (14) . This is also true of Sindbis virus infections. Whereas interjacent RNA was the major species of virus-specific RNA in Sindbis-infected cells, nearly all of the infectivity was found with the 42S peak (Fig. 3) The relevance of this pattern of viral RNA synthesis can be seen in Fig. 4 , which records a gradient analysis of labeled virus-specific RNA extracted from puromycin-treated and control cells. These data confirm that puromycin added 1.5 hr after infection inhibits '4C-uridine incorporation into virus-specific RNA. However, the inhibition is confined to the noninfectious interjacent RNA, thus explaining the lack of effect of puromycin on the appearance of infectious RNA.
One could argue that since protein synthesis has been nonspecifically inhibited, the nucleocapsid and envelope proteins were not available for virus assembly. Therefore, virion RNA accumulated within the drug-treated cells and masked a decreased rate of 42S RNA synthesis. However, in control cultures, only 6.2% of the total RNA labeled during this interval appeared in virus. This could account for less than onethird of the virion RNA present in the puromycintreated cells. Thus, the rate of 42S RNA synthesis, if decreased at all, was only slightly affected, whereas the synthesis of interjacent RNA was truly inhibited to a much greater extent.
This phenomenon is not a consequence of the particular mechanism of inhibition of protein synthesis, since the same preferential inhibition of interjacent RNA synthesis was seen in cells treated with cycloheximide (10 ,ug/ml) 1.5 hr after infection.
Preferential inhibition of interjacent RNA synthesis: temperature-shift experiments. The preceding studies showed that inhibition of protein synthesis early in the course of infection produced a distorted pattern of viral RNA synthesis with abnormally low levels of interjacent RNA. We hypothesized that this did not result from the general inhibition of protein synthesis but rather Most of these showed no significant difference between the shifted and the unshifted cultures. However, one of our RNA-mutants proved to have a similar and, indeed, an even more extremely distorted pattern of viral RNA synthesis.
Cells infected with mutant TS-24 were incubated at 29 C and were shifted from the permissive to the nonpermissive temperature of 41.5 C at 4.25 hr after infection. By this time, viral RNA synthesis had just begun. The monolayers were pulse-labeled with 3H-uridine for 40 min at 4.75, 5.75, and 6.75 hr, respectively. The labeled RNA was analyzed by sedimentation in 15 to 30% glycerol-SDS gradients. The synthesis of interjacent RNA was preferentially inhibited under these shift-up conditions (Fig. 5) . The control 4:1 ratio of 26S to 425 RNA evident in the 29 C cultures decreased to 0.94, 0.70, and 0.64 progressively in the shifted cells.
Cultures infected with the HR strain of Sindbis virus and treated in an identical manner did not show this effect (Fig. 6) . Although again there was a general, nonspecific increase in 3H-uridine incorporation in the shifted cultures, the sedi- We also measured ribonuclease-resistant virusspecific RNA in shifted and unshifted cultures. . Half of the cultures were shifted to 41.5 C at 4.25 hr after infection, whereas the others remained at 29 C. All cultures were incubated with medium containing 8H-uridine and were harvested for titration of infectious RNA and determination of incorporated radioactivity (Table 2 ). There was no significant difference in the infectivity of virus-specific RNA extracted from the cells infected by the wild type at either temperature or from the cells infected by TS-24 at 29 C. However, the mutant-infected culture shifted to 41.5 C showed an increase of about threefold. This approximates the value predicted by the sedimentation data of Fig. 4 (16) , who examined certain extreme physical conditions that permitted the interconversion of the interjacent and virion RNA. The suggestion that these two types of viral RNA are simply different physical forms of the same molecule is only the first step in defining the function, if indeed there is one, of the interjacent RNA. Note that every species of virus-specific RNA found in infected cells need not play a significant role; the replicative form is thought now to be a useless byproduct. However, the fact that the interjacent RNA represents a substantial fraction of the viral RNA synthetic activity throughout the infection indicates that it does have some function in the production of virus (8, 11, 14) . Sonnabend et al. (14) suggested that the interjacent RNA acts as messenger. Alternatively, it may aid in the assembly of the viral nucleocapsid or have some unidentified regulatory function.
Currently, little is known of the biosynthesis of interjacent RNA. Even the sequence of appearance of interjacent and virion RNA is uncertain. This question cannot be answered easily by the use of pulse-labeling techniques, since short pulses preferentially label the replicative intermediate, much of which sediments in the same region as the interjacent RNA.
The conditions used by Sreevalsan et al. (16) for in vitro interconversion of interjacent and virion RNA are far removed from those normally existing within cells. Thus, if these two species of RNA are alternative physical forms of the same molecule, their natural intracellular interconversion is probably mediated by some other molecule, presumably a protein, which could act catalytically or stoichiometrically. A relative deficiency of this hypothetical "conversion protein" could explain our results. Suppose that the initial product of viral RNA synthesis is virion RNA, part of which is subsequently converted to interjacent RNA. At 1.5 hr after infection, the cells might contain sufficient RNA synthetic enzymes to maintain normal RNA synthesis, but insufficient "conversion protein." Our results of inhibiting protein synthesis with puromycin early in the course of infection would thus be explained. Similarly, if the TS defect of mutant TS-24 lay in this "conversion protein," the temperature-shift experiments would parallel those seen with early inhibition of protein synthesis. This speculation has one interesting implication: mutant TS-24 is phenotypically RNA-; that is, it exhibits an almost total defect in viral RNA synthesis at the nonpermissive temperature. Hence, it is defective in a function essential for viral RNA synthesis, and this line of reasoning points to an essential role for interjacent RNA.
There are, of course, several presumptions inherent in this scheme. Although mutant TS-24 is phenotypically RNA-, it may also have other TS 121 VOL. 4, 1969 on September 28, 2017 by guest http://jvi.asm.org/ Downloaded from mutations in late functions that actually determine the conformation of the viral RNA. We have genetic evidence for three late functions (4, 5) . Two of these have been associated with specific virus-determined proteins (6) . Mutant TS-24 complements representatives of each of these three complementation groups and, thus, probably is not defective in any function that we have identified. Moreover, mutants with lesions in these late functions can show, if anything, a relative deficiency in the synthesis of 42S RNA (18) . Another case which may also affect late as well as early proteins is treatment of infected cells with low doses of interferon (9) . Here, too, the synthesis of virion RNA is inhibited to a greater extent than that of interjacent RNA. Nevertheless, other late functions may well not have been discovered as yet, and mutant TS-24 may possess a second mutation affecting one of these.
